CRISPR Therapeutics AG

CRSP · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $5.2B · 393 employees
202
SEC Filings
$55.62
Close 2026-07-01
393
Employees

Business Summary

CRISPR Therapeutics AG is a biopharmaceutical company focused on developing CRISPR/Cas9-based gene editing therapeutics. Its lead product, CASGEVY (exagamglogene autotemcel), received the world's first approval of a CRISPR-based therapy in 2023 for sickle cell disease and transfusion-dependent beta thalassemia, developed in collaboration with Vertex Pharmaceuticals. The company also pursues in vivo editing, allogeneic CAR T cell therapies for autoimmune and oncology indications, and regenerative medicine programs.

Latest Stock Quote

CRSP 2026-07-01 $55.62 O:$54.57 H:$57.25 L:$54.56 Vol:1.0M VWAP:$55.861
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-04

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-122025-12-310001193125-26-048957EDGAR125K words
2025-02-112024-12-310000950170-25-017899EDGAR—
2024-02-212023-12-310000950170-24-017571EDGAR—
2023-02-212022-12-310000950170-23-003441EDGAR—
2022-02-152021-12-310000950170-22-001282EDGAR—
2021-02-162020-12-310001564590-21-006074EDGAR—
2020-02-122019-12-310001564590-20-004355EDGAR—
2019-02-252018-12-310001564590-19-004115EDGAR—
2018-03-082017-12-310001564590-18-004920EDGAR—
2017-03-102016-12-310001564590-17-003977EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-032026-06-300001193125-26-330672EDGAR—
2025-11-102025-09-300001193125-25-273337EDGAR28K words
2025-08-042025-06-300000950170-25-102052EDGAR—
2025-05-062025-03-310000950170-25-064468EDGAR—
2024-11-052024-09-300000950170-24-121105EDGAR—
2024-08-052024-06-300000950170-24-090746EDGAR—
2024-05-082024-03-310000950170-24-055719EDGAR—
2023-11-062023-09-300000950170-23-059476EDGAR—
2023-08-072023-06-300000950170-23-039075EDGAR—
2023-05-082023-03-310000950170-23-018811EDGAR—
2022-11-012022-09-300000950170-22-020845EDGAR—
2022-08-082022-06-300000950170-22-015256EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-030001193125-26-330644EDGAR—
2026-03-160001193125-26-108333EDGAR55K words
2026-03-110001193125-26-101073EDGAR—
2026-02-120001193125-26-048873EDGAR—
2026-01-120001193125-26-009880EDGAR—
2025-11-100001193125-25-273329EDGAR—
2025-10-150001193125-25-240282EDGAR—
2025-08-040000950170-25-102027EDGAR—
2025-06-260000950170-25-090170EDGAR—
2025-06-090000950170-25-083799EDGAR—

202 total filings indexed. 170 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

hemoglobinopathies-(sickle-cell-disease,-transfusion-dependent-beta-thalassemia) oncology-(car-t-cell-therapies) autoimmune-diseases-(car-t-cell-therapies) regenerative-medicine in-vivo-gene-editing-for-common-and-rare-diseases crispr/cas9-gene-editing ex-vivo-cell-editing in-vivo-gene-editing sirna allogeneic-car-t-cell-therapy

Company Identity

CIK0001674416
TickerCRSP
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedV8
Websitehttps://www.crisprtx.com
Listed2016-10-19

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 13f33300b3e830699653b3583106fb668b482074b3d3e128e94e4420dcb99434
parent: 1ff64a583147ed3831431f600eae3258db88d0331e2b4afa507fe0d0a2a58e63
content hash: bce17a54430b3e9a3bcc597b4baf793a1045d7e20406fbb4fbd9e157e3ce5733
signed: 2026-08-13T19:02:18.190Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up CRSP using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on CRSP, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/CRSP (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.